hrp0092p2-176 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019

Efficacy and Safety of Growth Hormone (GH) in the Treatment of Children with Hypochondroplasia (HCH): Comparison with a Historical Cohort of Untreated Children with HCH

Pinto Graziella , Samara-Boustani Dinane , Viaud Magali , Cormier-Daire Valérie , Lopez Yeriley , Fresneau Laurence , Piketty Marie , Claude Pineau Jean , Polak Michel

Hypochondroplasia (HCH) is a skeletal dysplasia, mainly caused by mutations in the fibroblast growth factor receptor3 (FGFR3) gene and characterized by disproportionate short stature.Our main was to determine the efficacy of growth hormone therapy in children with HCH, compared with a historical cohort of 40 untreated children with HCH.Diagnosis of subjects was confirmed by the Bone Dysplasia Center2. Height standard dev...